Correction to: Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol
Trials. 2022 Feb 9;23(1):130.
doi: 10.1186/s13063-022-06073-7.
1 Primary Care EAP El Pla Sant Feliu de Llobregat, Primary Care Management Costa de Ponent, Catalan Institute of Health, L'Hospitalet de Llobregat, Spain. fmera@ambitcp.catsalut.net.
2 Institut Universitari de Recerca en Atenció Primària Jordi Gol i Gurina (IDIA PJGol), Barcelona, Spain. fmera@ambitcp.catsalut.net.
3 Institut Universitari de Recerca en Atenció Primària Jordi Gol i Gurina (IDIA PJGol), Barcelona, Spain.
4 Pharmacy Unit SAP Baix Llobregat Centre, Primary Care Management Costa Ponent. Catalan Institute of Health, Cornellà de Llobregat, Spain.
5 Primary Care Research Support Unit (USR) Costa de Ponent, Primary Care Management Costa de Ponent, Catalan Institute of Health, Cornellà de Llobregat, Spain.
6 Clinical Trials Research Unit (UICEC) IDIAPJGol, Platform SCReN, Barcelona, Spain.
7 Primary Care Research Support Unit (USR) Costa Ponent, Institut Universitari de Recerca en Atenció Primària Jordi Gol i Gurina (IDIAPJGol), Cornellà de Llobregat, Spain.
8 Primary Care Covid Notification and Monitoring Unit UNSC Metropolitana SUD, Primary Care Management Costa de Ponent, Catalan Institute of Health, L'Hospitalet de Llobregat, Spain.
9 Department of Pharmacology and Therapeutics, Universitat Autònoma de Barcelona, Bellaterra, Spain.